Nanotechnology and Nanomaterials in the Treatment and Diagnosis of Cancer: Correspondence

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2023 May 25

PMID 37228949

Authors

Soumeia Zeghoud

Deepak Chandran

Ilham Ben Amor

Hadia Hemmami

Pran Mohankumar

Talha Bin Emran

Affiliations

Soon will be listed here.

Citing Articles

Epilepsy Treatment and Diagnosis Enhanced by Current Nanomaterial Innovations: A Comprehensive Review.

He S, Zheng L, Li J, Liu S Mol Neurobiol. 2024; 62(1):946-961.

PMID: 38951470 DOI: 10.1007/s12035-024-04328-9.

Drug delivery methods based on nanotechnology for the treatment of eye diseases.

Oucif Khaled M, Zaater A, Ben Amor I, Zeghoud S, Ben Amor A, Hemmami H Ann Med Surg (Lond). 2023; 85(12):6029-6040.

PMID: 38098602 PMC: 10718325. DOI: 10.1097/MS9.0000000000001399.

References

Zhao J, Wallace M, Melancon M . Cancer theranostics with gold nanoshells. Nanomedicine (Lond). 2014; 9(13):2041-57. DOI: 10.2217/nnm.14.136. View

Jia S, Zhang R, Li Z, Li J . Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget. 2017; 8(33):55632-55645. PMC: 5589689. DOI: 10.18632/oncotarget.17184. View

Golombek S, May J, Theek B, Appold L, Drude N, Kiessling F . Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev. 2018; 130:17-38. PMC: 6130746. DOI: 10.1016/j.addr.2018.07.007. View

Jin C, Wang K, Oppong-Gyebi A, Hu J . Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review. Int J Med Sci. 2020; 17(18):2964-2973. PMC: 7646098. DOI: 10.7150/ijms.49801. View

Ben Amor I, Hemmami H, Eddine Laouini S, Temam H, Zaoui H, Barhoum A . Biosynthesis MgO and ZnO nanoparticles using chitosan extracted from Pimelia Payraudi Latreille for antibacterial applications. World J Microbiol Biotechnol. 2022; 39(1):19. DOI: 10.1007/s11274-022-03464-5. View

Bharali D, Mousa S . Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther. 2010; 128(2):324-35. DOI: 10.1016/j.pharmthera.2010.07.007. View

Zhou W, Gao X, Liu D, Chen X . Gold Nanoparticles for In Vitro Diagnostics. Chem Rev. 2015; 115(19):10575-636. PMC: 5226399. DOI: 10.1021/acs.chemrev.5b00100. View

Maeda H, Nakamura H, Fang J . The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2012; 65(1):71-9. DOI: 10.1016/j.addr.2012.10.002. View

Allen T, Cullis P . Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2012; 65(1):36-48. DOI: 10.1016/j.addr.2012.09.037. View

10.

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

11.

Roma-Rodrigues C, Rivas-Garcia L, Baptista P, Fernandes A . Gene Therapy in Cancer Treatment: Why Go Nano?. Pharmaceutics. 2020; 12(3). PMC: 7150812. DOI: 10.3390/pharmaceutics12030233. View

12.

Banerjee H, Verma M . Application of nanotechnology in cancer. Technol Cancer Res Treat. 2008; 7(2):149-54. DOI: 10.1177/153303460800700208. View

13.

Ickenstein L, Garidel P . Lipid-based nanoparticle formulations for small molecules and RNA drugs. Expert Opin Drug Deliv. 2019; 16(11):1205-1226. DOI: 10.1080/17425247.2019.1669558. View

14.

Seleci M, Ag Seleci D, Scheper T, Stahl F . Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging. Int J Mol Sci. 2017; 18(7). PMC: 5535907. DOI: 10.3390/ijms18071415. View

15.

Sharma A, Gothwal A, Kesharwani P, Alsaab H, Iyer A, Gupta U . Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. Drug Discov Today. 2016; 22(2):314-326. DOI: 10.1016/j.drudis.2016.09.013. View

16.

Kumar B, Singh S, Skvortsova I, Kumar V . Promising Targets in Anti-cancer Drug Development: Recent Updates. Curr Med Chem. 2017; 24(42):4729-4752. DOI: 10.2174/0929867324666170331123648. View

17.

Chinen A, Guan C, Ferrer J, Barnaby S, Merkel T, Mirkin C . Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence. Chem Rev. 2015; 115(19):10530-74. PMC: 5457709. DOI: 10.1021/acs.chemrev.5b00321. View

18.

Alam F, Naim M, Aziz M, Yadav N . Unique roles of nanotechnology in medicine and cancer-II. Indian J Cancer. 2016; 52(1):1-9. DOI: 10.4103/0019-509X.175591. View

19.

Fang M, Peng C, Pang D, Li Y . Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biol Med. 2013; 9(3):151-63. PMC: 3643664. DOI: 10.7497/j.issn.2095-3941.2012.03.001. View

20.

Mi Y, Shao Z, Vang J, Kaidar-Person O, Wang A . Application of nanotechnology to cancer radiotherapy. Cancer Nanotechnol. 2017; 7(1):11. PMC: 5167776. DOI: 10.1186/s12645-016-0024-7. View